Takeda Pharmaceutical Co Ltd ADR

Stock Chart, Company Information, and Scan Results

$15.83(as of Jun 23, 3:57 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Takeda Pharmaceutical Co Ltd ADR Company Information, Fundamentals, and Technical Indicators

Stock Price$15.83
Ticker SymbolTAK
ExchangeNyse
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees47,029
CountyUSA
Market Cap$49,386.9M
EBIDTA1,236,274.0M
10-Day Moving Average15.69
P/E Ratio0.25
20-Day Moving Average15.69
Forward P/E Ratio10.03
50-Day Moving Average16.39
Earnings per Share-0.30
200-Day Moving Average15.80
Profit Margin-2.22%
RSI39.60
Shares Outstanding3,159.7M
ATR0.28
52-Week High18.90
Volume2,212,590
52-Week Low12.78
Most Recent Support Level15.34
Book Value7,808,519.5M
Most Recent Resistance Level15.77
P/B Ratio0.01
Upper Keltner16.32
P/S Ratio0.01
Lower Keltner15.05
Debt-to-Equity Ratio16.32
Next Earnings Date07/28/2026
Cash Surplus-1,842,432.5M
Next Ex-Dividend DateUnknown

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix, and QDENGA brands. It has licensing and collaboration for the development and commercialization of products with Arrowhead Pharmaceuticals, Cour Pharmaceuticals, Engitix, Halozyme, Mirum Pharmaceuticals, Ucsd/Fortis Advisors, Zedira/Dr. Falk Pharma, Ac Immune, Acurastem, Anima Biotech, Biomarin, Denali Therapeutics, Luxna Biotech, Neurocrine Biosciences, Peptidream, Abbvie, Adimab, Ascentage Pharma, Crescendo Biologics, Exelixis, F-Star, Gsk, Heidelberg Pharma, Innovent Biologics, Keros Therapeutics, Kumquat Biosciences, Protagonist Therapeutics, Halozyme, Kamada, Johnson & Johnson/Momenta Pharmaceuticals, Previpharma, Novavax, Bridgene Biosciences, Charles River Laboratories, Iambic Therapeutics, Ipsen, Km Biologics, Massachusetts Institute Of Technology, and Nabla Bio. The company operates in Japan, the United States. Europe, Canada, Latin America, China, Asia, Russia/Commonwealth of Independent States, the Middle East, Oceania, and Africa. The company was founded in 1781 and is headquartered in Chuo, Japan.

Takeda Pharmaceutical Co Ltd ADR In Our Stock Scanner

As of Jun 23, 2026
example chart graphic
Scan Name: Low PE RatiosScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Undervalued StocksScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PS RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Blue Chip Stocks with Low PE RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.